Matrix solution 0.22%

Principle Routes of Exposure

Dermal ( Skin contact), Inhalation, Ingestion ACUTE EFFECTS OF EXPOSURE: Acute effects after a single exposure have been known to cause disruption of the menstrual cycle, uterine or abdominal cramping, increased or decreased uterine bleeding and headaches. CRONIC EFFECTS OF EXPOSURE: This product is not intended for human use. There has been no human use of this specific product. Such information is derived from known information associated with other progesterone containing substances. Long-term and repeated daily exposure has the potential for more untoward effects such as disruption of menstrual cycle, uterine or abdominal cramping, increased or decreased uterine bleeding, or prolongation of pregnancy. CARCINOGENIC EFFECT: This product is not considered a carcinogen and is not listed by OSHA, IRAC or NTP.

Medical Conditions Generally Aggravated by Exposure

People who should not handle this product include: Women who are pregnant or suspect they are pregnant; anyone with a thrombophlebitis or thromboembolic disorder or with a history of these events; people with cerebral-vascular or coronary- artery disease; women with known or suspected carcinoma of the breast; people with known or suspected estrogen-dependent neoplasm; women with undiagnosed vaginal bleeding; anyone with a benign or malignant tumor which developed during the use of oral contraceptives or other estrogen- containing products; anyone with liver dysfunction or disease.